Which Comes First: The Woman or Her Eggs?
By Ruha Benjamin,
Huffington Post
| 04. 17. 2013
[Quotes CGS's Marcy Darnovsky]
To Pay or Not to PayImagine two women sitting in a waiting room -- one is a store clerk, and the other is an investment banker -- preparing to donate their eggs for a particular type of stem cell research.* There are some who think that payment could coerce women, especially those who are low-income, to undergo the
invasive procedure.** Marcy Darnovsky, the executive director of the Center for Genetics and Society,
says that restricting payment can help prevent "the emergence of a market in which predominantly poor women are the ones who wind up selling their eggs."
Others insist that women are perfectly capable of weighing their options, and that egg donors should be financially rewarded for their time and trouble. UC Hastings law professor
Radhika Rao contends:
[E]veryone else involved in the production of human embryonic stem cells is entitled to compensation. The researchers who invest intellectual capital and the companies and universities that invest financial capital will surely share in any profits ... so why not those who provide the human capital in the form...
Related Articles
By Ian Sample, The Guardian | 03.08.2024
Scientists are a step closer to making IVF eggs from patients’ skin cells after adapting the procedure that created Dolly the sheep, the first cloned mammal, more than two decades ago.
The work raises the prospect of older women being...
By Ramon Antonio Vargas, The Guardian | 02.28.2024
Doctors say a man in California who contracted blood cancer while living with HIV is in remission from both potentially fatal illnesses thanks to a treatment they are hailing as remarkable and encouraging.
Paul Edmonds is only the fifth-known person...
By Victoria Gray, Uduak Thomas, and Kevin Davies, The CRISPR Journal | 02.14.2024
In July 2019, medical staff in Nashville dosed the first U.S. patient in the exa-cel therapy trial, sponsored by Vertex Pharmaceuticals and CRISPR Therapeutics. That first patient was Victoria Gray, a mother of four from Forest, Mississippi, a sickle cell...
By Adam Zewe, MIT News | 02.07.2024
A tiny device built by scientists at MIT and the Singapore-MIT Alliance for Research and Technology could be used to improve the safety and effectiveness of cell therapy treatments for patients suffering from spinal cord injuries.
In cell therapy, clinicians...